This video is an overview of the treatment and management of metastatic prostate cancer using a theranostic approach. Theranostics a portmanteau of therapeutics and diagnostics is a proposed process of diagnostic therapy for individual patients to test them for possible reaction to taking a new medication and to tailor a treatment for them based on the test results. Theranostics impact factor, overall ranking, rating, hindex. Theranostics has extended impact on patients in that more than individual centric care, guaranteed outcomes expected by patients seem to pose an alarming aspect of theranostics. Currently, the journal does not charge any publication or submission fees platinum open access. This journal with high impact factor offers an open access platform to the authors in academia and industry to publish their novel research. A broad spectrum of biomedical research that can be applied to future theranostic applications is encouraged. The new generation of biocompatible endogenous proteinbased nanoformulations is currently constructed through delivering cancer therapeutic and. The editorinchief is xiaoyuan chen national institute of biomedical imaging and bioengineering. Radiotheranostics in cancer diagnosis and management.
Theranostics is the combination of diagnosis and therapy. As the global impact of covid19 grows daily, our priority is always on the health and safety of our community and to protect our employees. Due to existing less targeted and tailored pharmacotherapy, the resulting loss in 40% of ineffective treatment has resulted in loss in overall economy of the. Targeting the srbi receptor for delivery of cancer theranostics warrants further research. Nanotheranostics publishes innovative and original basic, translational and clinical research reflecting the fields of nanomedicine, nanoimaging, drug and gene delivery, nanoelectronic. Current bioactive compounds if is decreased by a factor of 0.
Theranostics is a powerful therapeutic paradigm to the world of medical diagnosis and clinical practice paving the path for personalized medicine. The 3rd theranostics world congress 3twc took place on the campus of johns hopkins university on march 1214, 2015 the congress, cosponsored by the society of nuclear medicine and molecular imaging and johns hopkins medicine, was intended for chemists, physicists, technologists, physicians and all scientists and clinicians interested in translational research and current stateoftheart. Breaking news theranostics for prostate print email at the 2nd theranostics world congress there was progress towards the treatment of metastatic prostate cancer using a theranostics approach. International journal of theranostics high impact factor. These probes are typically liposomes, nanoparticles, micelles and viral vectors that are decorated with imaging reporters and deliver conventional therapy or molecularly targeted medicine such as complementary dna cdna or. Theranostics is a new field of medicine which combines specific targeted therapy based on. Nanotheranostics effectively brings together diagnostics and therapeutics onto a single platform, making them powerful tools in biomedicine. While the level of srbi expression on cancer cells will factor into the utility of this receptor for drug targeting, it is the mode of uptake that may have implications for lipoproteinmediated delivery of theranostic agents.
Lipoproteininspired nanoparticles for cancer theranostics. Nano theranostics effectively brings together diagnostics and therapeutics onto a single platform, making them powerful tools in biomedicine. Herein, therapeutic strategies such as nucleic acid delivery. This systematic integration of targeted diagnostics and therapeutics is aligned with the concept of personalized precision medicine, which is hoped to lead to improved patient outcome. Biotheranostics continues to monitor the novel coronavirus covid19. Theranostics and metabolotheranostics for precision medicine. Impact factor of journal theranostics 2016 2015 2014. Key words theranostics, herceptin, magnetic nanopartic les, egfr gene mutatio n. Paqr3 expression is downregulated in human breast cancers and correlated with her2 expression. Theranostics has extended impact on patients in that more. The major focus of this journal brain disorders journal with high impact factor. There is a rapid expansion of innovative nanoscale probes for theranostics that are being developed based on the imaging modality, the therapeutic cargo, and the target. Frontiers recent trends of the bioinspired nanoparticles. The terms personalized medicine, precision medicine, stratified medicine and p4 medicine are used.
Theranostics impact factor, overall ranking, rating, h. Theranostics is a multidisciplinary journal that publishes innovative and original research articles reflecting fields of in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, imageguided therapy, biosensor, nanobiosensor and bioelectronics, system biology and translational medicine, pointofcare and. In nuclear medicine, prostatespecific membrane antigen psma, a protein, can be employed as a potential target in patients with prostate cancer for detecting sites of disease spread. Led by shashikant kulkarni, our experienced editorial board members are all active researchers in their field. We are committed to continuing to serve our customers and. Theranostics australia is developing targeted molecular diagnostic imaging and therapeutic agents for the diagnosis and treatment of cancers. Personalized medicine has been introduced by hood in 2004, when he presented the predictive, personalized, preventive, and participatory p4 medicine approach 1.
Cosa has called for exercise to be embedded as part of standard practice in cancer care and to be viewed as an adjunct therapy that helps counteract the adverse effects of cancer. Preventing radiobleaching of cyanine fluorophores enhances. Cancer is the second leading cause of death in the usa according to the american cancer society. Ivyspring international publisher pty ltd level 32, 1 market street, sydney, nsw 2000, australia tel.
It is distributed in accordance with the creative commons attribution non commercial cc bync 4. The impact factor if 2018 of current bioactive compounds is 0. This charge state can have either a positive for instance, in case of increasing the efficiency of fishing of lowabundant proteins or negative effect for instance, in case of the appearance of charge jumps upon the injection of analyte solution into a measuring cell, what can cause undesirable. The human epidermal growth factor receptor 2 her2 expressed by approximately 2030% of breast cancers is another example of a receptor that can be used for theranostics. Radiotheranostics in cancer diagnosis and management radiology.
Remotely triggered nanotheranostics for cancer applications. Upregulation of hypoxiainducible factor antisense as a novel approach to treat ovarian cancer. Articles from theranostics are provided here courtesy of ivyspring international publisher. Tiangong lu, jianming tang, binita shrestha, blake r. The impact factor if, also denoted as journal impact factor jif, of an academic journal is a measure. Nanotheranostics, the sister journal of theranostics, is a multidisciplinary and fully open access journal. Lighttriggered theranostics based on photosensitizerconjugated carbon dots for simultaneous enhancedfluorescence imaging and photodynamic therapy. Cancer genetics is a part of elsevier s oncology journal network.
Paqr3 plays a suppressive role in laryngeal squamous cell carcinoma. The articles in the current issue of the international journal of theranostics have attained this status after passing various scrutiny processes. Current bioactive compounds impact factor, overall. Theranosticspublishes innovative research articles reflecting the fields of in vitrodiagnostics and prognostics, in vivomolecular imaging, molecular therapeutics, imageguided therapy, biosensors, system biology and translational medicine, personalized medicine and a broad spectrum of biomedical research that can be applied to future theranostic applications. Current issue international journal of theranostics. Ergo, multimodal theranostics therapy plus diagnostic nanomedicine has emerged as a providential paradigm in cancer therapy lammers et al. Theranostics impact factor 20182019 the impact factor if 2018 of theranostics is 8. The impact factor if, also denoted as journal impact factor jif, of an academic journal is a measure of the yearly average number of citations to recent articles published in that.
Current bioactive compounds impact factor, overall ranking. Supramolecular pegylated dendritic systems as phredox dual. This excitement originates from the success of fda approved abraxane albuminbased paclitaxel nanoparticles in 2005. A reference style for endnote may also be downloaded from here. Theranostic nanomedicine for cancer detection and treatment. Articles published in the lancet oncology regularly receive coverage in the mainstream print, online, and. The impact factor if or journal impact factor jif of an academic journal is a scientometric factor based on the yearly average number of citations on articles published by a particular journal in the last two years. Recent advances in theranostics and challenges for the future. Theranostics publishes innovative research articles reflecting the fields of in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image. Trastuzumab, a humanized monoclonal antibody directed against the extracellular domain of her2 has provided a breakthrough in the treatment of her2 positive metastatic. Special issue smart nanobiointerfaces for theranostics. Deep tissue photoacoustic imaging of nickel ii dithiolenecontaining polymeric nanoparticles in the second nearinfrared window byullee park 1, kyung min lee 2,6, suhyeon park 3, misun yun 4, hakjong choi 4, jeesu kim 1, changho lee 3,5, hyungwoo kim 6, chulhong kim 1. Theranostics and metabolotheranostics for precision. Despite the large interest in nuclearoptical multimodality imaging, the effect of radiation on the.
Effect of dialysis dose and membrane flux in maintenance hemodialysis. Psma may also be the target for systemic treatment of advanced prostate cancer. Employing theranostic nanoparticles, which combine both therapeutic and diagnostic capabilities in one dose, has promise to propel the biomedical field toward personalized medicine. Since its inception until date, theranostics has been fostering unremarkable tailored and targeted therapy. Theranostics a portmanteau of therapeutics and diagnostics is a proposed process of diagnostic therapy for individual patients to test them for possible reaction to taking a new medication and to tailor a treatment for them based on the test results theranostics would be a key part of personalized medicine and require considerable advances in predictive medicine. The aim of cancer genetics is to publish high quality scientific papers on the cellular, genetic and molecular aspects of cancer, including cancer predisposition and. Personalized medicine, precision medicine, or theranostics is a medical model that separates people into different groupswith medical decisions, practices, interventions andor products being tailored to the individual patient based on their predicted response or risk of disease. According to the journal citation reports, the journal has a 2016 impact factor of 8. It covers biomedical research of interest for theranostics abstracting and indexing. The fundamental principle of theranostics has been followed since decades, with the utilization of radioiodine to diagnose image and manage cancers of thyroid gland which dates back to 1940. The concept of personalized nanomedicine is the backbone of nanotheranostics. This even more true when using nanoscale structures, of which optical, eletrochemical and biological properties make them optimal biosensing transducers for theranostics agents. Apr 27, 2018 over the past decade, more interests have been aroused in engineering proteinbased nanoformulations for cancer treatment. Theranostics publishes innovative research articles reflecting the fields of in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, imageguided therapy, biosensors, system biology and translational medicine, personalized medicine and a broad spectrum of biomedical research that can be applied to future theranostic applications.
In other words, the impact factor of 2020 is the average of the number of cited publications divided by the citable. Check out our website au for further information, look at the videos, research and papers we provide. Highly sensitive biosensor systems are particularly sensitive to the charge state of an analyte. Nov 22, 2014 theranostics is a term that has been used in the context of molecular targeting vectors eg, peptides labeled either with diagnostic or with therapeutic radionuclides for the diagnosis and therapy of a particular disease, targeted specifically by the vector at its molecular level. At the 3rd theranostics world congress that progress continued from the bench and to the bedside. Theranostics, a merger between portmanteau diagnosis and therapy, provides unique approach with tailored treatment plan and the study explores targeted, safe, and efficient pharmacotherapy based on uniqueness of every individual thus resulting in. The journal ranks third out of 229 oncology journals worldwide, and is the leading clinical oncology research journal 2018 journal citation reports, clarivate analytics 2019. Theranostics rg journal impact rankings 2018 and 2019. Citescore values are based on citation counts in a given year e. Bioinspired proteinbased nanoformulations for cancer. We are committed to continuing to serve our customers and patients despite the evolving situation.
1382 339 1441 46 759 7 845 9 1090 739 155 1168 139 1369 583 460 692 1307 644 139 892 1029 278 316 337 139 827 609 202 553 1343 25 871 772 78 1438 776 353 487 725 322 161